IGC Pharma (IGC) Prepaid Assets (2011 - 2026)
IGC Pharma (IGC) reported Prepaid Assets of $155000.0 for Q1 2026, down 54.68% year-over-year from $342000.0 in Q1 2025, and up 1092.31% quarter-over-quarter from $13000.0 in Q4 2025.
IGC Pharma (IGC) Prepaid Assets (2011 - 2026) Analysis & Trends
IGC Pharma (IGC) has 16 years of Prepaid Assets data on file, last reported at $155000.0 in Q1 2026.
- Prepaid Assets for Q1 2026 came in at $155000.0, down 54.68% year-over-year; the trailing twelve-month figure through Mar 2026 was $155000.0 (down 54.68% YoY), and the FY2026 annual result was $155000.0, down 54.68% from the prior year.
- Prepaid Assets improved to $155000.0 in Q1 2026 per IGC's latest filing, from $13000.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $358000.0 in Q1 2023 and troughed at $13000.0 in Q4 2025.
- A 5-year average of $167117.6 and a median of $148000.0 in 2025 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2025: Prepaid Assets surged 1225.0% in 2022, then slumped 95.72% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $322000.0 in 2022, then sank by 61.49% to $124000.0 in 2023, then jumped by 145.16% to $304000.0 in 2024, then tumbled by 95.72% to $13000.0 in 2025, then soared by 1092.31% to $155000.0 in 2026.
- Business Quant data shows IGC's Prepaid Assets at $155000.0 in Q1 2026, $13000.0 in Q4 2025, and $130000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 155,000.00 |
| Dec 31, 2025 | 13,000.00 |
| Sep 30, 2025 | 130,000.00 |
| Jun 30, 2025 | 148,000.00 |
| Mar 31, 2025 | 342,000.00 |
| Dec 31, 2024 | 304,000.00 |
| Sep 30, 2024 | 198,000.00 |
| Jun 30, 2024 | 34,000.00 |
| Mar 31, 2024 | 41,000.00 |
| Dec 31, 2023 | 124,000.00 |
| Sep 30, 2023 | 143,000.00 |
| Jun 30, 2023 | 54,000.00 |
| Mar 31, 2023 | 358,000.00 |
| Dec 31, 2022 | 322,000.00 |
| Sep 30, 2022 | 146,000.00 |
| Jun 30, 2022 | 159,000.00 |
| Mar 31, 2022 | 170,000.00 |
| Dec 31, 2021 | 1.70 Mn |
| Sep 30, 2021 | 1.67 Mn |
| Jun 30, 2021 | 12,000.00 |